Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""CIRCULATING tumor DNA"" wg kryterium: Temat


Tytuł:
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Autorzy:
Alden SL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lee V; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Narang AK; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Meyer J; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gearhart SL; Department of Surgery, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.
Christenson ES; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło:
The oncologist [Oncologist] 2024 Mar 04; Vol. 29 (3), pp. e414-e418.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Rectal Neoplasms*/diagnostic imaging
Rectal Neoplasms*/genetics
Rectal Neoplasms*/therapy
Humans ; Neoadjuvant Therapy ; Retrospective Studies ; Chemoradiotherapy
Czasopismo naukowe
Tytuł:
Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.
Autorzy:
Bando H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Yamaguchi K; Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Mitani S; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Sawada K; Department of Clinical Oncology, Kushiro Rosai Hospital, Kushiro, Japan.
Mishima S; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Komine K; Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan.
Okugawa Y; Department of Genomic Medicine, Mie University Faculty of Medicine, Tsu, Japan.
Hosoda W; Department of Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.
Ebi H; Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Advanced Cancer Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło:
Cancer science [Cancer Sci] 2024 Mar; Vol. 115 (3), pp. 1014-1021. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Humans ; Japan ; Proto-Oncogene Proteins B-raf/genetics ; Mutation ; Molecular Diagnostic Techniques ; Disease Progression ; Medical Oncology
Czasopismo naukowe
Tytuł:
Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer.
Autorzy:
Eckhoff AM; Department of Surgery, Duke University, Durham, NC, USA.
Kanu E; Department of Surgery, Duke University, Durham, NC, USA.
Fletcher A; Department of Surgery, Duke University, Durham, NC, USA.
Bao M; Department of Surgery, Duke University, Durham, NC, USA.
Aushev VN; Natera, Austin, TX, USA.
Spickard E; Natera, Austin, TX, USA.
Nussbaum DP; Department of Surgery, Duke University, Durham, NC, USA.
Allen PJ; Department of Surgery, Duke University, Durham, NC, USA. .
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2024 Mar; Vol. 31 (3), pp. 1444-1446. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Letter
MeSH Terms:
Pancreatic Neoplasms*/surgery
Circulating Tumor DNA*/genetics
Adenocarcinoma*/surgery
Humans ; Male ; Female ; Infant ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Biomarkers, Tumor/genetics
Opinia redakcyjna
Tytuł:
Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges.
Autorzy:
Xue Y; Department of Hematology, The First Hospital of China Medical University, 110001 Shenyang, Liaoning, China.
Xia X; Department of Hematology, The First Hospital of China Medical University, 110001 Shenyang, Liaoning, China.
Liu X; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 230031 Hefei, Anhui, China.
Zheng Y; Department of Hematology, The First Hospital of China Medical University, 110001 Shenyang, Liaoning, China.
Gu H; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 230031 Hefei, Anhui, China.; University of Science and Technology of China, 230026 Hefei, Anhui, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, 230031 Hefei, Anhui, China.
Wang X; Department of Hematology, The First Hospital of China Medical University, 110001 Shenyang, Liaoning, China.
Pokaż więcej
Źródło:
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2024 Feb 22; Vol. 29 (2), pp. 86.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Circulating Tumor DNA*/genetics
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Myelodysplastic Syndromes*/diagnosis
Myelodysplastic Syndromes*/genetics
Myelodysplastic Syndromes*/pathology
Hematologic Neoplasms*
Humans ; Neoplasm, Residual/diagnosis ; Neoplasm, Residual/genetics
Czasopismo naukowe
Tytuł:
High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.
Autorzy:
Huang L; Medical Center on Aging of Ruijin Hospital, MCARJH, Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China. .; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Lv Y; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Guan S; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Yan H; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Han L; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Wang Z; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. .
Han Q; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. .
Dai G; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. .
Shi Y; Department of General Surgery, Shanghai Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, 358 Datong Road, Gaoqiao Town, Shanghai, 200137, China. sy_.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 20; Vol. 22 (1), pp. 184. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/pathology
Adenocarcinoma*/genetics
Albumins*
Paclitaxel*
Humans ; Prospective Studies ; Prognosis ; CA-19-9 Antigen ; Proto-Oncogene Proteins p21(ras)/genetics ; Mutation/genetics ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancer.
Autorzy:
Martens GA; Department of Laboratory Medicine, AZ Delta General Hospital, Roeselare; Department of Biomolecular Medicine, Ghent University, Ghent. Electronic address: .
Demol J; Department of Oncology, AZ Delta General Hospital, Roeselare.
Dedeurwaerdere F; Department of Pathology, AZ Delta General Hospital, Roeselare.
Breyne J; Department of Laboratory Medicine, AZ Delta General Hospital, Roeselare.
De Smet K; Department of Radiology, AZ Delta General Hospital, Roeselare.
De Jaeger P; Department of RADar Learning and Innovation Center, AZ Delta General Hospital, Roeselare, Belgium.
De Smet D; Department of Laboratory Medicine, AZ Delta General Hospital, Roeselare.
Pokaż więcej
Źródło:
ESMO open [ESMO Open] 2024 Feb; Vol. 9 (2), pp. 102235. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Breast Neoplasms*/drug therapy
Humans ; Female ; Biomarkers, Tumor/genetics ; Disease Progression ; Class I Phosphatidylinositol 3-Kinases/genetics
Czasopismo naukowe
Tytuł:
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma.
Autorzy:
Powles T; Barts Cancer Institute, Queen Mary University of London ECMC, Barts Health, London, UK. Electronic address: .
Assaf ZJ; Roche/Genentech, South San Francisco, CA, USA.
Degaonkar V; Roche/Genentech, South San Francisco, CA, USA.
Grivas P; University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA.
Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Oudard S; Georges Pompidou European Hospital, University of Paris, Paris, France.
Gschwend JE; Department of Urology, Rechts der Isar Medical Center, Technical University Munich, Munich, Germany.
Albers P; Department of Urology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Castellano D; Medical Oncology Department CIBER-ONC, University Hospital 12 de Octubre, Madrid, Spain.
Nishiyama H; Department of Urology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Daneshmand S; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
Sharma S; Natera, Inc, San Carlos, CA, USA.
Sethi H; Natera, Inc, San Carlos, CA, USA.
Aleshin A; Natera, Inc, San Carlos, CA, USA.
Shi Y; Roche/Genentech, South San Francisco, CA, USA.
Davarpanah N; Roche/Genentech, South San Francisco, CA, USA.
Carter C; Roche/Genentech, South San Francisco, CA, USA.
Bellmunt J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Mariathasan S; Roche/Genentech, South San Francisco, CA, USA.
Pokaż więcej
Źródło:
European urology [Eur Urol] 2024 Feb; Vol. 85 (2), pp. 114-122. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/drug therapy
Carcinoma, Transitional Cell*/genetics
Carcinoma, Transitional Cell*/pathology
Circulating Tumor DNA*/genetics
Urinary Bladder Neoplasms*
Antibodies, Monoclonal, Humanized*
Humans ; Prospective Studies ; Treatment Outcome ; Neoplasm Recurrence, Local ; Adjuvants, Immunologic/therapeutic use ; Muscles/pathology ; Recurrence ; Antineoplastic Combined Chemotherapy Protocols
Czasopismo naukowe
Tytuł:
Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review.
Autorzy:
Crupi E; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milano, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: .
de Padua TC; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milano, Italy.
Marandino L; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milano, Italy.
Raggi D; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milano, Italy.
Dyrskjøt L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Sonpavde GP; Genitourinary Oncology and Phase I Clinical Research Unit, AdventHealth Cancer Institute and the University of Central Florida, Orlando, FL, USA.
Kamat AM; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Necchi A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milano, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Pokaż więcej
Źródło:
European urology oncology [Eur Urol Oncol] 2024 Feb; Vol. 7 (1), pp. 44-52. Date of Electronic Publication: 2023 Jun 15.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Circulating Tumor DNA*
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/pathology
Humans ; Prognosis ; Prospective Studies ; Neoplasm Recurrence, Local/genetics ; Muscles/pathology ; Biomarkers
Czasopismo naukowe
Tytuł:
Liquid biopsy for precision diagnostics and therapeutics.
Autorzy:
Anitha K; Department of Pharmacology, School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur 425405, India.
Posinasetty B; PROMETRIKA LLC, 100 Cambridge Park, Cambridge, MA 02140, United States.
Naveen Kumari K; Sri Krishna Teja Pharmacy College, Tirupati, Andhra Pradesh 517502, India.
Chenchula S; All India Institute of Medical Sciences, Bhopal 462020, India. Electronic address: .
Padmavathi R; SVS Medical College, Hyderabad, Telangana, India.
Prakash S; All India Institute of Medical Sciences, Bhopal 462020, India.
Radhika C; Sri Venkateswara College of Pharmacy, Chittoor, AP, India.
Pokaż więcej
Źródło:
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2024 Feb 01; Vol. 554, pp. 117746. Date of Electronic Publication: 2023 Dec 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cell-Free Nucleic Acids*
Circulating Tumor DNA*/genetics
Neoplastic Cells, Circulating*
Humans ; Liquid Biopsy ; Biopsy ; Biomarkers, Tumor
Czasopismo naukowe
Tytuł:
Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma.
Autorzy:
Kim EY; Georgetown University School of Medicine, Washington, District of Columbia; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
Ruiz ES; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Hanna GJ; Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Thakuria M; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Silk AW; Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: Ann_.
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Feb; Vol. 90 (2), pp. 427-429. Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Skin Neoplasms*/diagnosis
Skin Neoplasms*/genetics
Skin Neoplasms*/pathology
Circulating Tumor DNA*/genetics
Humans ; Biomarkers, Tumor
Czasopismo naukowe
Tytuł:
Liquid biopsy in colorectal cancer: Onward and upward.
Autorzy:
Torresan S; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy; Department of Medicine, University of Udine, 33100 Udine, Italy.
de Scordilli M; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy; Department of Medicine, University of Udine, 33100 Udine, Italy. Electronic address: .
Bortolot M; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy; Department of Medicine, University of Udine, 33100 Udine, Italy.
Di Nardo P; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Foltran L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Fumagalli A; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Guardascione M; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Ongaro E; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy; Department of Medicine, University of Udine, 33100 Udine, Italy.
Pokaż więcej
Źródło:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Feb; Vol. 194, pp. 104242. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cell-Free Nucleic Acids*/genetics
Circulating Tumor DNA*/genetics
Circulating Tumor DNA*/analysis
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Humans ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; Liquid Biopsy
Czasopismo naukowe
Tytuł:
Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma.
Autorzy:
Tamura D; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
Abe M; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.; Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Japan.
Hiraki H; Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Japan.
Sasaki N; Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Japan.
Yashima-Abo A; Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Japan.
Ikarashi D; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
Kato R; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
Kato Y; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
Maekawa S; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
Kanehira M; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
Takata R; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
Maejima K; Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Sasagawa S; Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Fujita M; Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Suzuki Y; Department of Computational Biology and Medical Sciences, The University of Tokyo, Kashiwa, Japan.
Nakagawa H; Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Iwaya T; Department of Clinical Oncology, Iwate Medical University School of Medicine, Yahaba, Japan.
Nishizuka SS; Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Japan.
Obara W; Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
Pokaż więcej
Źródło:
Cancer science [Cancer Sci] 2024 Feb; Vol. 115 (2), pp. 529-539. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*
Carcinoma, Transitional Cell*/diagnosis
Carcinoma, Transitional Cell*/genetics
Carcinoma, Transitional Cell*/surgery
Circulating Tumor DNA*/genetics
Humans ; Prospective Studies ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Biomarkers ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
Autorzy:
Zhang Y; Department of Infectious diseases, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Du H; Department of Emergency, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Wang N; Department of Molecular Biology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Wang L; Department of Thoracic Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Huang Y; Department of Medical oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 24; Vol. 24 (1), pp. 129. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/therapy
Humans ; Databases, Factual ; Gene Library ; Genes, cdc
Czasopismo naukowe
Tytuł:
Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis.
Autorzy:
Lu J; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.; The First Affiliated Hospital of Zhejiang, Chinese Medical University, (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
Feng Y; Hangzhou TCM Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Guo K; Department of Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Sun L; The First Affiliated Hospital of Zhejiang, Chinese Medical University, (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China. .
Ruan S; The First Affiliated Hospital of Zhejiang, Chinese Medical University, (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China. .
Zhang K; The First Affiliated Hospital of Zhejiang, Chinese Medical University, (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China. .; Anji Traditional Chinese Medical Hospital, Huzhou, Zhejiang, China. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Jan 22; Vol. 150 (1), pp. 25. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/surgery
Circulating Tumor DNA*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Adenocarcinoma of Lung*
Humans ; Prognosis ; Prospective Studies ; Retrospective Studies ; Biomarkers
Czasopismo naukowe
Tytuł:
Liquid biopsy in colorectal cancer.
Autorzy:
Najafi S; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Majidpoor J; Department of Anatomy, School of Medicine, Infectious Diseases Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.
Mortezaee K; Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. Electronic address: .
Pokaż więcej
Źródło:
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2024 Jan 15; Vol. 553, pp. 117674. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cell-Free Nucleic Acids*
Circulating Tumor DNA*
Neoplastic Cells, Circulating*/pathology
Colorectal Neoplasms*/diagnosis
Humans ; Liquid Biopsy ; Biomarkers, Tumor
Czasopismo naukowe
Tytuł:
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
Autorzy:
Alig SK; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Shahrokh Esfahani M; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Garofalo A; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Li MY; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
Rossi C; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.; Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France.
Flerlage T; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA.
Flerlage JE; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
Adams R; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA.
Binkley MS; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA.
Shukla N; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Jin MC; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Olsen M; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Telenius A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
Mutter JA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Schroers-Martin JG; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Sworder BJ; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Rai S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
King DA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Schultz A; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Bögeholz J; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Su S; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA.
Kathuria KR; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Liu CL; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Kang X; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Strohband MJ; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Langfitt D; Department of Bone Marrow Transplant and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN, USA.
Pobre-Piza KF; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA.
Surman S; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA.
Tian F; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Spina V; Laboratory of Molecular Diagnostics, Department of Medical Genetics EOLAB, Bellinzona, Switzerland.
Tousseyn T; Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Buedts L; Department of Human Genetics, KU Leuven, Leuven, Belgium.
Hoppe R; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA.
Natkunam Y; Department of Pathology, Stanford University, Stanford, CA, USA.
Fornecker LM; Institut de Cancérologie Strasbourg Europe (ICANS) and University of Strasbourg, Strasbourg, France.
Castellino SM; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.
Advani R; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Rossi D; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Lynch R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ghesquières H; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France.
Casasnovas O; Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France.
Kurtz DM; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.
Marks LJ; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA.
Link MP; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA.
André M; Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
Vandenberghe P; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Department of Hematology, University Hospitals Leuven, Leuven, Belgium.
Steidl C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
Diehn M; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA. .
Alizadeh AA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA. .
Pokaż więcej
Źródło:
Nature [Nature] 2024 Jan; Vol. 625 (7996), pp. 778-787. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Genomics*
Hodgkin Disease*/blood
Hodgkin Disease*/classification
Hodgkin Disease*/diagnosis
Hodgkin Disease*/genetics
Circulating Tumor DNA*/blood
Circulating Tumor DNA*/genetics
Genome, Human*/genetics
Humans ; Mutation ; Reed-Sternberg Cells/metabolism ; Tumor Microenvironment ; Single-Cell Gene Expression Analysis
Czasopismo naukowe
Tytuł:
Circulating Tumor DNA Dynamics: A New Approach in Revolutionizing Cancer Management.
Autorzy:
Surendran AK; Department of General Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
Mavani PT; B.J. Medical College, Gujarat University, Ahmedabad, India. .
Vijayakumar C; Department of General Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2024 Jan; Vol. 31 (1), pp. 163-164. Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:
Letter; Comment
MeSH Terms:
Circulating Tumor DNA*/genetics
Neoplasms*/genetics
Neoplasms*/therapy
Neoplasms*/pathology
Neoplastic Cells, Circulating*/pathology
Humans ; Liquid Biopsy ; Biomarkers, Tumor/genetics
Opinia redakcyjna
Tytuł:
Dynamic analysis of predictive biomarkers for radiation therapy efficacy in non-small cell lung cancer patients by next-generation sequencing based on blood specimens.
Autorzy:
Zhang X; Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Huang X; Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Cao Y; Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Mao Y; Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Zhu Y; Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Zhang Q; Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Zhang T; Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Chang L; Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Wang C; Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2024 Jan; Vol. 253, pp. 154972. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Circulating Tumor DNA*/genetics
Humans ; Biomarkers, Tumor/genetics ; Mutation/genetics ; High-Throughput Nucleotide Sequencing
Czasopismo naukowe
Tytuł:
Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients.
Autorzy:
Sánchez-Martín V; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481), 28029, Madrid, Spain.
López-López E; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain.
Reguero-Paredes D; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain.
Godoy-Ortiz A; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481), 28029, Madrid, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain.
Domínguez-Recio ME; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain.
Jiménez-Rodríguez B; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481), 28029, Madrid, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain.
Alba-Bernal A; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain; Andalusia-Roche Network in Precision Medical Oncology, 41092, Sevilla, Spain.
Elena Quirós-Ortega M; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain; Andalusia-Roche Network in Precision Medical Oncology, 41092, Sevilla, Spain.
Roldán-Díaz MD; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain.
Velasco-Suelto J; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain.
Linares-Valencia N; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain.
Garrido-Aranda A; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain; Andalusia-Roche Network in Precision Medical Oncology, 41092, Sevilla, Spain.
Lavado-Valenzuela R; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481), 28029, Madrid, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain; Andalusia-Roche Network in Precision Medical Oncology, 41092, Sevilla, Spain.
Álvarez M; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481), 28029, Madrid, Spain; Andalusia-Roche Network in Precision Medical Oncology, 41092, Sevilla, Spain; University of Málaga, Faculty of Medicine, 29010 Malaga, Spain.
Pascual J; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481), 28029, Madrid, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain; Andalusia-Roche Network in Precision Medical Oncology, 41092, Sevilla, Spain.
Alba E; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481), 28029, Madrid, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain; Andalusia-Roche Network in Precision Medical Oncology, 41092, Sevilla, Spain; University of Málaga, Faculty of Medicine, 29010 Malaga, Spain. Electronic address: .
Comino-Méndez I; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481), 28029, Madrid, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga, Spain; Andalusia-Roche Network in Precision Medical Oncology, 41092, Sevilla, Spain. Electronic address: .
Pokaż więcej
Źródło:
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2024 Jan 01; Vol. 552, pp. 117673. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Cell-Free Nucleic Acids*
Circulating Tumor DNA*/genetics
Triple Negative Breast Neoplasms*
Humans ; Biomarkers, Tumor/genetics ; Mutation ; Polymerase Chain Reaction/methods
Czasopismo naukowe
Tytuł:
Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes.
Autorzy:
Kim JJ; Department of Laboratory Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Kim HM; Department of Pathology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Kim H; Department of Laboratory Medicine, Chung-Ang University Gwangmyung Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
Kim SJ; Division of Hemato-Oncology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Lee ST; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Choi JR; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Shin S; Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Hwang DY; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 314-323. Date of Electronic Publication: 2023 Jul 17.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Lymphoma*
Humans ; Liquid Biopsy ; Mutation ; Biomarkers, Tumor/genetics ; High-Throughput Nucleotide Sequencing
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies